FAKTOR OPTIONSSCHEIN - BRISTOL-MYERS SQUIBB | Market Closed - BOERSE MUENCHEN 14:27:02 2024-05-31 EDT | ||
| 11.7 EUR | -3.11% |
|
| 1 month | +12.64% | ||
| 3 months | +41.26% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Latest news about BRISTOL-MYERS SQUIBB COMPANY
More news
| Date | Price | Change |
|---|---|---|
| 24-05-31 | 11.7 | -3.11% |
| 24-05-30 | 12.08 | -0.62% |
| 24-05-29 | 12.15 | +1.17% |
| 24-05-28 | 12.01 | +4.74% |
| 24-05-27 | 11.47 | -0.80% |
Real-time BOERSE MUENCHEN
Last update May 31, 2024 at 02:27 pm
More quotesStatic data
| Product type | Exotic Products |
|---|---|
| Buy / Sell | CALL |
| Underlying | BRISTOL-MYERS SQUIBB COMPANY |
| Issuer | Goldman Sachs |
| WKN | GG402F |
| ISIN | DE000GG402F4 |
| Date issued | 2024-02-20 |
| Strike | 60.38 $ |
| Maturity | Unlimited |
| Parity | 1.52 : 1 |
| Emission price | 8.62 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 12.35 € |
|---|---|
| Lowest since issue | 7.005 € |
| Spread | 0.02 € |
| Spread % | 0.17% |
Company Profile
Bristol-Myers Squibb Company est spécialisé dans le développement, la fabrication et la commercialisation de produits pharmaceutiques. Les produits sont destinés au traitement des cancers, des maladies cardio-vasculaires, de l'hépatite, des maladies immunitaires et des désordres psychiatriques.
The United States account for 70.1% of net sales.
Sector
-
Ratings for Bristol-Myers Squibb Company
Trading Rating
Investor Rating
ESG Refinitiv
B
Consensus: Bristol-Myers Squibb Company
Sell
Buy
Mean consensus
HOLD
Number of Analysts
26
Last Close Price
41.09
USD
Average target price
53.19
USD
Spread / Average Target
+29.46%
- Stock Market
- Certificates
- Certificat
